The Role of Midodrine for Hypotension Outside of the Intensive Care Unit

Midodrine is an oral, peripherally acting alpha-adrenergic agonist. After gaining Food and Drug Administration (FDA) approval in 1996 for orthostatic hypotension, its use has evolved to target vasoplegic conditions such as intradialytic hypotension in the end-stage renal disease population, refracto...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Canadian Journal of Clinical Pharmacology (Online) 2017-01, Vol.24 (3), p.e45-e50
Hauptverfasser:	Gutman, Lawrence B, Wilson, Ben J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic alpha-Agonists - adverse effects Adrenergic alpha-Agonists - therapeutic use Humans Hypotension - diagnosis Hypotension - drug therapy Intensive Care Units Midodrine - adverse effects Midodrine - therapeutic use Prodrugs - adverse effects Prodrugs - therapeutic use Pruritus - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!